Spots Global Cancer Trial Database for Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
Official Title: A Randomized, Double-blind Study to Assess the Safety and Efficacy of Different Dose Levels of Pasireotide (SOM230) Subcutaneous (sc) Over a 6 Month Treatment Period in Patients With de Novo, Persistent or Recurrent Cushing's Disease
Study ID: NCT00434148
Conditions
Interventions
Study Description
Brief Summary: This study will evaluate the safety and efficacy of two different doses of Pasireotide in patients with de novo or recurrent/persistent Cushing's Disease.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Stanford University Medical Center Stanford Cancer Center (3), Stanford, California, United States
University Chicago Hospital Dept. of Univ of Chicago, Chicago, Illinois, United States
Dana Farber Cancer Institute The Melanoma Program, Boston, Massachusetts, United States
Columbia University Medical Center- New York Presbyterian Columbia University DeptofMed, New York, New York, United States
Cleveland Clinic Foundation Dept. of Cleveland Clinic (6), Cleveland, Ohio, United States
Oregon Health & Sciences University Dept.ofOregonHealth&SciencesU., Portland, Oregon, United States
University of Texas Southwestern Medical Center Clinical-TranslationalRes.Ctr., Dallas, Texas, United States
University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(8), Houston, Texas, United States
Baylor College of Medicine, Houston, Texas, United States
Swedish Medical Center Dept.ofSeattle Neuroscience(2), Seattle, Washington, United States
Novartis Investigative Site, Capital Federal, Buenos Aires, Argentina
Novartis Investigative Site, Buenos Aires, , Argentina
Novartis Investigative Site, Buenos Aires, , Argentina
Novartis Investigative Site, Edegem, , Belgium
Novartis Investigative Site, Gent, , Belgium
Novartis Investigative Site, Curitiba, PR, Brazil
Novartis Investigative Site, Rio de Janeiro, RJ, Brazil
Novartis Investigative Site, Porto Alegre, RS, Brazil
Novartis Investigative Site, Ribeirao Preto, SP, Brazil
Novartis Investigative Site, Sao Paulo, SP, Brazil
Novartis Investigative Site, São Paulo, SP, Brazil
Novartis Investigative Site, Edmonton, Alberta, Canada
Novartis Investigative Site, Halifax, Nova Scotia, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Beijing, Beijing, China
Novartis Investigative Site, Beijing, , China
Novartis Investigative Site, Shanghai, , China
Novartis Investigative Site, Arhus, , Denmark
Novartis Investigative Site, Copenhagen, , Denmark
Novartis Investigative Site, Herlev, , Denmark
Novartis Investigative Site, Helsinki, , Finland
Novartis Investigative Site, Angers, , France
Novartis Investigative Site, Grenoble Cédex 9, , France
Novartis Investigative Site, LILLE Cedex, , France
Novartis Investigative Site, Limoges cedex, , France
Novartis Investigative Site, Marseille cedex 05, , France
Novartis Investigative Site, Paris, , France
Novartis Investigative Site, Pessac Cedex, , France
Novartis Investigative Site, St Priest en Jarez Cedex, , France
Novartis Investigative Site, Toulouse Cedex 9, , France
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Essen, , Germany
Novartis Investigative Site, Muenchen, , Germany
Novartis Investigative Site, Würzburg, , Germany
Novartis Investigative Site, Athens, GR, Greece
Novartis Investigative Site, Athens, GR, Greece
Novartis Investigative Site, Haifa, , Israel
Novartis Investigative Site, Heifa, , Israel
Novartis Investigative Site, Jerusalem, , Israel
Novartis Investigative Site, Petach Tikva, , Israel
Novartis Investigative Site, Ancona, AN, Italy
Novartis Investigative Site, Cona, FE, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Milano, MI, Italy
Novartis Investigative Site, Padova, PD, Italy
Novartis Investigative Site, Pisa, PI, Italy
Novartis Investigative Site, Orbassano, TO, Italy
Novartis Investigative Site, Torino, TO, Italy
Novartis Investigative Site, Napoli, , Italy
Novartis Investigative Site, México, Distrito Federal, Mexico
Novartis Investigative Site, México, Distrito Federal, Mexico
Novartis Investigative Site, Warszawa, , Poland
Novartis Investigative Site, Porto, , Portugal
Novartis Investigative Site, Sevilla, Andalucia, Spain
Novartis Investigative Site, Barcelona, , Spain
Novartis Investigative Site, Ankara, , Turkey
Novartis Investigative Site, Balcova / Izmir, , Turkey
Novartis Investigative Site, Fatih / Istanbul, , Turkey
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
